NCT02404818已完成不适用
UFPTI 1431 - HL02: Investigating Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Survivors Treated With Either Photon or Proton Radiation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5
- 试验地点
- 1
- 主要终点
- Cardiac Abnormalities As Measured By Cardiac MRI
研究概览
简要总结
The purpose of this study is to evaluate if radiation and chemotherapy treatment cause cardiac abnormalities among survivors of Hodgkin's lymphoma.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Completed radiation and chemotherapy treatment for Hodgkin lymphoma involving the mediastinum.
- •Patient must be ≥ 18 years at time of consent.
排除标准
- •Pregnant women at time of Cardiac MRI
- •Contraindications to Cardiac MRI (contrast allergy, metal implants, medical devices)
- •Glomerular filtration rate (GFR) < 30, unless approved by Radiologist (UF Health Jacksonville Radiology Policy: Administration of Gadolinium-Based Contrast Agents).
结局指标
主要结局
Cardiac Abnormalities As Measured By Cardiac MRI
时间窗: Day 1
Cardiac Abnormalities As Measured By Echocardiogram
时间窗: Day 1
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac ChangesClinical Stage 0 Esophageal Adenocarcinoma AJCC V8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC V8Clinical Stage I Esophageal Adenocarcinoma AJCC V8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC V8Clinical Stage II Esophageal Adenocarcinoma AJCC V8Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC V8Clinical Stage IIA Esophageal Adenocarcinoma AJCC V8Clinical Stage IIB Esophageal Adenocarcinoma AJCC V8Clinical Stage III Esophageal Adenocarcinoma AJCC V8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC V8Localized Esophageal CarcinomaLocalized Lung CarcinomaPathologic Stage 0 Esophageal Adenocarcinoma AJCC V8Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage I Esophageal Adenocarcinoma AJCC V8Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IA Esophageal Adenocarcinoma AJCC V8Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IB Esophageal Adenocarcinoma AJCC V8Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IC Esophageal Adenocarcinoma AJCC V8Pathologic Stage II Esophageal Adenocarcinoma AJCC V8Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IIA Esophageal Adenocarcinoma AJCC V8Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IIB Esophageal Adenocarcinoma AJCC V8Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage III Esophageal Adenocarcinoma AJCC V8Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC V8Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC V8Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC V8Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC V8Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC V8Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC V8Stage 0 Lung Cancer AJCC V8Stage I Lung Cancer AJCC V8Stage IA1 Lung Cancer AJCC V8Stage IA2 Lung Cancer AJCC V8Stage IA3 Lung Cancer AJCC V8Stage IB Lung Cancer AJCC V8Stage II Lung Cancer AJCC V8Stage IIA Lung Cancer AJCC V8Stage IIB Lung Cancer AJCC V8Stage III Lung Cancer AJCC V8Stage IIIA Lung Cancer AJCC V8Stage IIIB Lung Cancer AJCC V8Stage IIIC Lung Cancer AJCC V8Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage I Esophageal Adenocarcinoma AJCC v8Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8Pathologic Stage II Esophageal Adenocarcinoma AJCC v8Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage III Esophageal Adenocarcinoma AJCC v8Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8Stage 0 Lung Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8NCT04183218Mayo Clinic24
已完成
不适用
Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer PatientsCardiotoxicityNCT04790266Oncology Institute of Southern Switzerland150
已完成
不适用
Early Detection of Cardiovascular Changes After Radiotherapy for Breast CancerBreast Cancer FemaleNCT03297346Institut de Radioprotection et de Surete Nucleaire250
招募中
不适用
Cardiac Magnetic Resonance for Early Detection of Chemotherapy or Radiation Therapy Induced Cardiotoxicity in Breast Cancer (CareBest)Chemotherapy Induced CardiotoxicityNCT03301389Yonsei University2,000
终止
不适用
Cardiotoxic Effects of Chemotherapy in Patients With Sarcomas: A Two and Three-dimensional Echocardiographic Speckle Tracking Imaging StudySarcomaNCT06511388Mayo Clinic400